BofA analyst Joshua Dennerlein lowered the firm’s price target on Medical Properties Trust (MPW) to $3 from $3.50 and keeps an Underperform rating on the shares. The firm continues to believe the company is in a “difficult situation,” with the key concern surrounding its ability to pay off or refinance its debt maturing in 2026 or 2027, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPW:
- Medical Properties Trust prospect to sell managed care unit to Astrana for $745M
- Medical Properties Trust Reports Q3 2024 Results
- Medical Properties Trust reports Q3 normalized FFO 16c, consensus 20c
- MPW Upcoming Earnings Report: What to Expect?
- Medical Properties: Independent investigation found no evidence of wrongdoing